Articles Posted in Misrepresentation

Published on:

Ruhnn Holding Limited (RUHN), a publicly-traded fashion and lifestyle company headquartered in China, is the subject of a class action lawsuit.  The complaint for the lawsuit alleges that Ruhnn made statements that were false and/or misleading and/or didn’t disclose important information to shareholders.  The class period includes all persons who purchased shares of Ruhnn pursuant to its April 3, 2019 initial public offering (IPO). The deadline to apply to be lead plaintiff, or class representative, is December 6, 2019.Ruhnn Holding Limited (RUHN), a publicly-traded fashion and lifestyle company headquartered in China, is the subject of a class action lawsuit.

The complaint for the lawsuit alleges that Ruhnn made statements that were false and/or misleading and/or didn’t disclose important information to shareholders.

The class period includes all persons who purchased shares of Ruhnn pursuant to its April 3, 2019 initial public offering (IPO). The deadline to apply to be lead plaintiff, or class representative, is December 6, 2019. Continue reading

Published on:

In January 2018, Menlo Therapeutics went public issuing over 8,000,000 shares of common stock at a public offering price of $17.00 raising over 125 million dollars.  NASDAQ lists Menlo’s stock under the ticker symbol “MNLO.”

Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities served as the lead underwriters.  Menlo’s stock price, MNLO, initially skyrocketed.  However, the stock recently plummeted after poor test results costing investors millions of dollars.

Contact Our Firm if You’ve Invested in Menlo Therapeutics (“MNLO”)

Badges
Contact Us
Free Consultation (800) 975-4345